I have extensive expertise in: 

​

• Genomics (next-generation sequencing [NGS], genome-wide association studies [GWAS], single nucleotide polymorphisms [SNPs], whole genome sequencing [WGS], whole exome sequencing [WES], polygenic diseases)

• Gene therapy (gene-editing, CRISPR, adeno-associated vectors [AAV], lenti-viral vectors [LVV])

• Cell therapy (CAR-T)

• Oncology (lymphoma, melanoma, ovarian cancer, prostate cancer)

• Autoimmunity (Crohn’s disease, ulcerative colitis, lupus)

• Rare diseases (Alexander disease, familial chylomicronemia syndrome, hereditary angioedema)

• Cancer therapy (biologics, biomarkers, cell and gene therapy, checkpoint inhibitors [anti-CTLA-4, PD-1 inhibitors], immunotherapy, bispecific antibodies)